Advancing Viral Vector Manufacturing: NGS-Driven Solutions for Manufacturing Robustness, Product Safety & Regulatory Compliance

• Addressing analytical gaps in viral vector identity, genome integrity, impurity profiles and batch comparability
• Evaluating the role of sequencing in identifying truncated genomes and sequence integrity that impact potency and safety
• Discussing how NGS can be adopted in cGMP environments to meet identity, purity, safety, and comparability requirements

Speakers:

Kok Seong Lim

Independent Cell & Gene Therapy CMC Expert

Independent Expert